Despite decades of research, the mechanisms behind fast flashes of insight that change how a person perceives their world, ...
Pegcetacoplan injections slowed progression of geographic atrophy but had no impact on visual acuity in a real-world setting, ...
In a multicenter randomized trial, tenecteplase did not improve vision recovery compared with aspirin when given within 4.5 hours of acute central retinal artery occlusion (CRAO). The ...
A new imaging breakthrough combines ultrasound and light-based techniques to generate vivid 3D images that show both tissue ...
In this expert perspective from Retina 2026, Baruch D. Kuppermann, MD, PhD, discusses positive data from real-world studies ...
Central retinal artery occlusion (CRAO) is an ophthalmic emergency that usually leads to sudden and permanent blindness, and ...
Intravenous tenecteplase does not improve vision recovery and is associated with greater incidence of adverse events ...
Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results